FDMT · 4D Molecular Therapeutics, Inc.
$9.61
-0.24 (-2.44%)
At close · Jul 29
Market Cap
$681.74M
Shares
69.21M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-06-01 | $250,000,000 | — | 2026-03-18 | — | 10-K , filed 2026-03-18 |
Key facts
CIK
1650648
CUSIP
35104E100
13F (30d)
22 filings
22 filers
Visit website
Investor relations